loading animation for AJAX calls

181 Reports in Pharmaceuticals

Antibiotics: Technologies and Global Markets

Published - May 2014 | Publisher - BCC Publishing| Code - PHM025C

The global systemic antibiotics market was valued at $39.6 billion in 2013 and is expected to reach $41.2 billion by 2018, at a CAGR of 0.8%.

JAK and PI3K Signaling Pathway Markets

Published - Apr 2014 | Publisher - BCC Publishing| Code - PHM168A

The global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012. This market is expected to grow to $464.5 million in 2013 and $2.2 billion in 2018 with a compound annual growth rate (CAGR) of 36.8% over the five-year period from 2013 to 2018.

Diagnostics and Therapeutics for HIV: Global Markets

Published - Apr 2014 | Publisher - BCC Publishing| Code - PHM058B

The global market for HIV therapeutics is expected to grow to $18.2 billion in 2013 and $19.6 in 2018, with a compound annual growth rate (CAGR) of 1.5%.

Drugs for Treating Systemic Lupus Erythematosus: Global Markets

Published - Mar 2014 | Publisher - BCC Publishing| Code - PHM159A

The global market for drugs to treat systemic lupus erythematosus (SLE) is expected to reach $950.2 million in 2013 and $2.6 billion in 2018, a compound annual growth rate (CAGR) of 22.4%.

Cancer Immunology and Oncolytic Virology: Technologies and Global...

Published - Mar 2014 | Publisher - BCC Publishing| Code - PHM129A

The global cancer immunotherapies market reached $30.8 billion in 2012. This market is expected to grow to nearly $34.3 billion in 2013 and $67.9 billion in 2018 with a compound annual growth rate (CAGR) of 14.7% over the five-year period, 2013 to 2018.

Neurostimulation: Technologies and Global Markets

Published - Mar 2014 | Publisher - BCC Publishing| Code - PHM149A

The global neurostimulation devices market is expected to reach $3.8 billion in 2013 and $4.1 billion in 2018, with a compound annual growth rate (CAGR) of 1.5%.

Histone Deacetylase Inhibitors: Emerging Markets

Published - Feb 2014 | Publisher - BCC Publishing| Code - PHM163A

The global histone deacetylase inhibitor (HDI) market reached $153 million in 2011 and $223.2 million in 2012. This market is expected to be valued at $361.8 million in 2013 and $954.3 million by 2018, a compound annual growth rate (CAGR) of 21.4%.

Antibody Drug Conjugates: Technologies and Global Markets

Published - Feb 2014 | Publisher - BCC Publishing| Code - PHM161A

The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%.

Over-the-Counter (OTC) Drugs and Dietary Supplements: Global Mark...

Published - Feb 2014 | Publisher - BCC Publishing| Code - PHM050B

The global market for OTC medicines and dietary supplements reached $128.8 billion in 2012. This market is expected to reach to $142.7 billion in 2013 and $189.7 billion in 2018, with a compound annual growth rate (CAGR) of 5.9%.

Drugs for Treating Mental Disorders: Technologies and Global Mark...

Published - Feb 2014 | Publisher - BCC Publishing| Code - PHM074B

The global market for drugs used in mental disorders was $70.1 billion in 2012 and $68.9 billion in 2013. This market is expected to rise at a compound annual growth rate (CAGR) of 2.3% from 2013 to 2018 and reach $77.1 billion by 2018.

Global Markets for Generic Drugs

Published - Jan 2014 | Publisher - BCC Publishing| Code - PHM009G

The global generics sector reached $269.8 billion in 2012. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.

Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global...

Published - Jan 2014 | Publisher - BCC Publishing| Code - PHM153A

The global market for circulating tumor cell (CTC) technology reached nearly $2.8 billion in 2012 and $3.7 billion in 2013. This market is estimated to reach nearly $8.9 billion by 2018, demonstrating a compound annual growth rate (CAGR) of 18.9% for the five-year period, 2013 to 2018.

Global Markets and Technologies for Advanced Drug Delivery System...

Published - Jan 2014 | Publisher - BCC Publishing| Code - PHM006J

The global revenue for advanced drug delivery systems is estimated to be $151.3 billion in 2013. In 2018,  revenues are estimated to reach nearly $173.8 billion, demonstrating a compound annual growth rate (CAGR) of 2.8%.

In Vitro Toxicity Testing: Technologies and Global Markets

Published - Jan 2014 | Publisher - BCC Publishing| Code - PHM017E

The global in vitro toxicity testing market was valued at $4 billion in 2011 and more than $4.9 billion in 2012. This market is estimated to reach nearly $9.9 billion in 2017, with a compound annual growth rate (CAGR) of 14.7% for the five-year period, 2012 to 2017.

2013 Oncology Research Review

Published - Dec 2013 | Publisher - BCC Publishing| Code - PHM126B

This BCC Research review provides highlights from oncology and other related market research reports published in 2013. It covers topics like uterine cancer, ovarian cancer, cervical cancer, prostrate cancer, and hematological disorders.

2013 Pharmaceuticals Research Review

Published - Dec 2013 | Publisher - BCC Publishing| Code - PHM099D

This BCC Research review provides highlights from pharmaceutical market research reports published in 2013. It covers topics like antithrombotic drugs, anticoagulant drugs, drug device combinations, sexually transmitted diseases, histone methyltransferases, and ubiquitin proteasome.

The Global Influenza Market

Published - Nov 2013 | Publisher - BCC Publishing| Code - PHM049C

The global influenza market will grow from nearly $3.8 billion in 2012 to $4 billion in 2013. Market revenue is forecast to increase at a five-year compound annual growth rate (CAGR) of 8% from 2013 to 2018, totaling nearly $6 billion in 2018.

Excipients in Pharmaceuticals

Published - Oct 2013 | Publisher - BCC Publishing| Code - PHM010H

The global excipient market reached nearly $5.9 billion in 2012. This market is expected to grow to $6.3 billion in 2013 and then to $8.8 billion in 2018, a compound annual growth rate (CAGR) of 6.9% over the five-year period from 2013 to 2018.

Medicines for Smoking Cessation: Global Markets

Published - Sep 2013 | Publisher - BCC Publishing| Code - PHM154A

In 2012, the global smoking cessation medicine market had an estimated value of $2.11 billion. Estimated revenues in 2013 will be $2.12 billion. The market will observe growth after 2013 with a compound annual growth (CAGR) of 3.4% to reach $2.5 billion in 2018.

Global Markets for Contract Pharmaceutical Manufacturing, Researc...

Published - Aug 2013 | Publisher - BCC Publishing| Code - PHM043E

The global market for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging was $219.9 billion in 2012. This market is estimated to reach $242.2 billion in 2013 and $374.8 billion by 2018, a five-year compound annual growth rate (CAGR) of 9.1%.

Global Markets for Vaccine Technologies

Published - Jul 2013 | Publisher - BCC Publishing| Code - PHM014E

Global revenue for vaccine technologies was nearly $31.8 billion in 2011. This market is expected to increase from $33.6 billion in 2012 to $43.4 billion in 2017 at a compound annual growth rate (CAGR) of 5.3%.

Regenerative Medicines: Bone and Joint Applications

Published - Jun 2013 | Publisher - BCC Publishing| Code - PHM032C

The U.S. market for regenerative medicine products used in bone and joint applications was estimated to total $2.72 billion in 2012 and is projected to increase to $2.73 billion in 2013. The market should total nearly $3.9 billion by 2018 and have a five-year compound annual growth rate (CAGR) of 7.3%.

Ubiquitin Proteasome: Global Markets for Research Tools, Diagnost...

Published - Jun 2013 | Publisher - BCC Publishing| Code - PHM066B

The global market for ubiquitin proteasome research and development was estimated at nearly $2.9 billion in 2013. The market should total more than $5.5 billion by 2018, and have a five-year compound annual growth rate (CAGR) of 14.2% from 2013 to 2018.

Global Markets for Orphan Drugs

Published - Jun 2013 | Publisher - BCC Publishing| Code - PHM038D

The global market for orphan drugs reached nearly $86.1 billion in 2012. The market is expected to reach $112.1 billion in 2017 for a compound annual growth rate (CAGR) of 5.4%.

Skin Disease Treatment Technologies and Global Markets

Published - May 2013 | Publisher - BCC Publishing| Code - PHM127A

The global dermatology markets reached $15.8 billion in 2012. The market is expected to reach $16.1 billion in 2013 and $18.5 billion in 2018 for a CAGR of 2.8%.

« 3 4 5 6 7 »

1 Upcoming Reports in Pharmaceuticals

Significant Drug Launches in 2019: A BCC Research Analysis and Insights on Pharmaceutical Industry

Target Date - Sep 2019| Publisher - BCC Publishing | Code - PHM220A| Price - $5,500
Report Includes
  • Information on the top potential drug launches by pharma companies in 2019
  • Knowledge about drug, mechanism of action, and briefing of clinical evidences
  • Detailed information and insights on the drug Upadacitinib which is manufactured by AbbVie Inc. , Ultomiris (ravulizumab-cwvz) a humanized monoclonal antibody manufactured by Alexion Pharmaceuticals Inc. and many more
  • Insights into regulatory approvals, market scope, and analysis of pipeline molecules
  • Detailed profiles of the companies and competitors related to the industry
 
Get Notified when New Reports are published
MEMBERSHIP

 

CUSTOM